2018 Annual Report & Accounts


27 February 2019

ConvaTec Group Plc (“ConvaTec” or the “Group”), a leading global medical products and technologies company, has today published on the Group’s website its Annual Report & Accounts for the year ended 31 December 2018 (the "Annual Report").

In compliance with Listing Rule 9.6.1, a copy of the Annual Report will also shortly be submitted to the National Storage Mechanism and will be available for inspection at

The Annual Report, together with notice of the Group’s Annual General Meeting to be held on 9 May 2019, will be sent to shareholders in due course, at which point a further announcement will be made.


About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.



Analysts and Investors 




John Crosse, VP Investor Relations

+44 (0)7500 141435




Mark Reynolds, Director Investor Relations

+44 (0)7551 036625








Bobby Leach, VP Group Corporate Affairs                      

+44 (0)7770 842226





+44 (0)207 2513801






Cookies are needed for this website to work optimally. They also help us to know a little bit about how you use our website, which improves the browsing experience.  Cookies on this site are used for traffic measurement and optimisation of page content only. By continuing to browse on this website, you indicate your consent to the use of cookies.  You may block the use of cookies by following the "How to block and avoid cookies" instructions

Learn more about our Cookie policy